Our flagship herbal extract product, Beyond Wealth-CS, recently received strong recognition at two prestigious events: the 2025 Taiwan Livestock and Aquaculture Expo and the 2025 AI and Animal Health Industry Forum. These events brought together key players in the animal health sector, where our presentation was met with enthusiastic response from both industry professionals and academic experts.
During the events, our technical specialist delivered a keynote titled “Strategies for Using Beyond Wealth-CS in the Prevention and Treatment of Coccidiosis and Avian Leucocytozoonosis (chicken leucocytozoonosis).” The presentation introduced Beyond Wealth-CS as a novel phytogenic veterinary drug, highlighting its dual immunomodulatory and antiparasitic mechanisms that enhance host resistance and reduce pathogen load. This natural yet scientifically grounded approach provides an effective alternative to conventional antibiotics.
Beyond Wealth-CS demonstrated excellent performance in on-site evaluations and clinical observations, attracting strong interest from industry professionals, researchers, and potential collaborators both domestically and internationally. These interactions have opened promising channels for further cooperation and market development.
Looking ahead, we remain committed to advancing herbal technology and expanding the global application of Beyond Wealth-CS in animal health. Our mission is to deliver safe, natural, and effective solutions for disease prevention and sustainable livestock management.